Hormone regimen and how recently used may determine cancer risk
A new study of 3,823 post-menopausal women found that continuous combined hormone therapy(estrogen combined with 25 to 31 days per month of progestin use) was associated with an increased breast cancer risk among current users of the regimen who had been taking it for five or more years. The study however did not find any association// between use of continuous combined hormone therapy an...Night Time Aspirin Regimen Found to Reduce Blood Pressure
Patients with mild hypertension experienced a significant reduction in blood pressure as the result of regularly taking aspirin before bed, according to a new study. To investigate the effect of aspirin taken at different times of the rest-activity cycle, Ramon C. Hermida, Ph.D., of Bioengineering and Chronobiology Laboratories, University of Vigo, Campus Universitario, Spain, and colleag...Simplest therapeutic regimen found less effective against HIV
Antiretroviral therapy for treatment of Human Immunodeficiency Virus type 1 (HIV-1) infection has improved steadily since the advent of combination therapy in 1996//. More recently, new drugs have been approved, offering added dosing convenience and improved safety profiles, while some previously popular drugs are being used less often as their drawbacks become better defined. Resistance...Protective regimen for acute Graft-versus-host disease
Allogeneic hematopoietic-cell transplantation with the use of conditioning regimens of non-myeloablative radiotherapy, chemotherapy, or both to decrease early toxic effects extends the possibility of hematopoietic-cell// transplantation to patients older than 50 years and those with coexisting conditions. However, acute graft-versus-host disease (GVHD) remains a major problem after non-...Four-Drug AIDS Treatment Regimen Deemed Of No Use
The inclusion of a fourth drug to the usual three-drug HIV treatment regimen is not warranted, according to researchers. The fourth drug did not reduce the HIV load// or the drug resistance, the new study said. It is published in the August 16 issue of JAMA, a theme issue on HIV/AIDS. Roy M. Gulick, M.D., M.P.H., of Weill Medical College of Cornell University, New York, presented the...MabThera Significantly Increases Survival of Lymphoma Patients Regardless of Chemotherapy Regimen
Data published today in the Journal of the National CancerInstitute BASEL, Switzerland, 2 May 2007 - In a study published today inthe Journal of the National Cancer Institute, the innovative cancerdrug MabThera was shown to improve overall survival in patientswith lymphoma regardless of the chemotherapy regimen used.1 Thereview further s...